ASX:LSHLifespot Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lifespot Health Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeA$0.05MA: A$0.05▼A$0.0752-Week Range N/AVolume120,633 shsAverage VolumeN/AMarket Capitalization$3.80 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartInsider TradesHeadlines Lifespot Health Ltd, together with its subsidiaries, focuses on the development and commercialization of medical diagnostic and monitoring technology solutions in Australia and Germany. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; and Seng-Vital, a digitally integrated cannabis vaporizer. Lifespot Health Ltd is headquartered in Fitzroy, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Lifespot Health. Previous Next 2.6 Community Rank Outperform VotesLifespot Health has received 11 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLifespot Health has received 10 “underperform” votes. (Add your “underperform” vote.)Community SentimentLifespot Health has received 52.38% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Lifespot Health and other stocks. Vote “Outperform” if you believe LSH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LSH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLifespot Health does not currently pay a dividend.Dividend GrowthLifespot Health does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Lifespot Health insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Lifespot Health is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lifespot Health is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.52 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolASX:LSH Previous Symbol CUSIPN/A CIKN/A Webhttp://www.lifespot-health.com/ Phone61 3 9191 0135Debt Debt-to-Equity RatioN/A Current Ratio2.84 Quick Ratio2.47Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$241,391.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.71 Book ValueA$0.01 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares87,697,296Market Cap$3.80 million Next Earnings DateN/A OptionableNot Optionable Receive LSH News and Ratings via Email Sign-up to receive the latest news and ratings for LSH and its competitors with MarketBeat's FREE daily newsletter. Lifespot Health (ASX:LSH) Frequently Asked Questions Has Lifespot Health been receiving favorable news coverage? Media stories about LSH stock have been trending very negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Lifespot Health earned a news impact score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutLifespot Health. Who are some of Lifespot Health's key competitors? Some companies that are related to Lifespot Health include Deepmatter Group (DMTR), Genedrive (GDR), Dorsavi (DVL), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), Smiles Inclusive (SIL), Imaging Dynamics (IDL), Cryosite (CTE), 3D Signatures (DXD), Med Biogene (MBI), BioMark Diagnostics (BUX), Carl Data Solutions (CRL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH) and Imagin Medical (IME). Who are Lifespot Health's key executives? Lifespot Health's management team includes the following people: Mr. Justyn Peter Stedwell, Company Sec.Mr. Stefan Schraps, Chief Exec. Officer & Managing Director of BodyTel GmbH (Age 46) What is Lifespot Health's stock symbol? Lifespot Health trades on the ASX under the ticker symbol "LSH." How big of a company is Lifespot Health? Lifespot Health has a market capitalization of $0.00 and generates $241,391.00 in revenue each year. View additional information about Lifespot Health. What is Lifespot Health's official website? The official website for Lifespot Health is http://www.lifespot-health.com/. How can I contact Lifespot Health? The company can be reached via phone at 61 3 9191 0135. This page was last updated on 4/6/2020 by MarketBeat.com StaffFeatured Article: What are popular green investing opportunities?
